Immune-Integrated Wound Models Aim to Close the Translational Gap in Skin Repair
Impaired wound healing and pathological scarring remain stubborn problems in dermatology and reconstructive care, and immune dysregulation sits at the center of both. The review presents a clear argument: conventional in vitro systems are too simple to capture the immune choreography that governs human skin repair, especially when inflammation lingers and fibroblasts drift toward fibrosis. In that setting, models that include immune cells are not an academic luxury. They are a practical requirement for studying why some wounds heal and others harden into chronic, disordered scars.
Human wound repair depends on tightly timed interactions among keratinocytes, fibroblasts, endothelial cells, and immune populations. When those signals skew, the tissue can remain trapped in a pro-inflammatory state, with persistent cytokine activity, excess extracellular matrix deposition, and abnormal remodeling. Simple monocultures cannot reproduce that environment, and even many traditional co-culture systems flatten the dynamic exchange that takes place in living tissue. The review frames immune cell integration as the critical step needed to approximate the pathological microenvironment more faithfully.
From Static Co-Culture to Dynamic Perfusion Platforms
The article organizes current progress across several model classes, each with a distinct level of biological realism. Two-dimensional co-cultures remain the most accessible entry point, allowing researchers to combine immune cells with skin-relevant cells in controlled systems. Their value lies in simplicity and experimental flexibility, but they still struggle to recreate tissue architecture, mechanical forces, and the spatial gradients that shape inflammatory repair.
Three-dimensional static cultures move closer to the structure of real tissue. By enabling cells to interact in a matrix-like environment, these systems better approximate cell adhesion, migration, and matrix deposition. In wound biology, those factors matter because immune cells do not act in isolation; they move through evolving extracellular matrices, release mediators, and influence fibroblast behavior in ways that can either resolve inflammation or intensify scarring. Static 3D systems improve that context, yet they still lack circulation and do not easily reproduce the continuous exchange of soluble factors found in vivo.
Organoid systems add another layer of complexity by generating self-organizing tissue-like structures. In skin research, they offer a more faithful cellular organization than flat cultures, and their ability to host multiple cell types makes them attractive for disease modeling. Even so, their use in immune-driven wound pathology remains limited by the difficulty of sustaining stable immune populations over time and by the challenge of maintaining reproducible tissue behavior across experiments.
Organ-on-a-Chip Brings Mechanical and Immune Cues Together
Among the platforms discussed, organ-on-a-chip technology carries the greatest promise for modeling aberrant wound healing. Its appeal rests on three features that matter directly to wound biology: dynamic perfusion, mechanical stimulation, and multicellular crosstalk. Those features allow investigators to simulate blood flow, nutrient delivery, and the physical forces that influence tissue repair, while also preserving communication among immune cells and structural skin cells.
In chronic or fibrotic wounds, immune activation does not occur in a vacuum. Flow conditions, shear stress, and changing matrix stiffness can all alter how macrophages, T cells, and fibroblasts behave. A microfluidic platform can mimic those shifting conditions far better than a static dish. The review positions this technology as especially useful for reproducing inflammation and fibrosis, two pathological processes that define many difficult-to-treat wounds and scarring disorders.
One sentence captures the practical value of the field’s direction: immune cells are no longer treated as accessory components in wound models, but as central drivers of disease behavior.
Why Immune Cells Change the Biology of Scarring Models
The review emphasizes that immune cell integration improves the ability of models to reproduce the signaling cascades behind pathological repair. Inflammatory mediators shape fibroblast activation, keratinocyte migration, vascular responses, and matrix turnover. Once those pathways remain activated for too long, the wound environment shifts away from orderly closure and toward fibrosis. That biology explains why models without immune components often fail when asked to predict human response.
By incorporating immune cells, researchers can study how early inflammatory events evolve into persistent tissue remodeling. That includes examining the transition from acute repair to chronic inflammation, as well as the amplification loops that promote excess collagen deposition. For translational research, this matters because precision therapeutics depend on identifying which immune pathways are causing the system to stall.
The review does not claim that one platform is sufficient for every question. Instead, it argues for model selection based on the biological problem under study. A simple co-culture may be enough for screening a cytokine pathway, while a microfluidic chip may be necessary to examine how perfusion and immune trafficking interact during fibrosis. The right model depends on the level of tissue realism required, the duration of culture, and the endpoint under investigation.
Standardization, Cell Stability, and Long-Term Culture Remain the Main Obstacles
Several constraints still limit the field. Cell source stability remains a major issue, especially when immune cells must remain viable and phenotypically consistent over time. Standardization is another barrier, since model design, matrix composition, flow conditions, and readout methods differ widely between laboratories. Long-term culture viability also remains difficult, particularly in systems that attempt to combine multiple cell types with mechanical stimulation and complex architecture.
Those limitations are not minor technical details. They shape whether a model can be trusted to reflect human biology rather than a laboratory artifact. Without reproducibility, even elegant systems can lose their value for mechanistic research or therapeutic testing.
Emerging strategies offer a path forward. The review points to combinations such as organ-on-a-chip with three-dimensional bioprinting and modular design concepts. These approaches could help build more biomimetic, higher-throughput platforms that are easier to tailor to specific wound phenotypes. Bioprinting may improve spatial organization, while modular systems may allow researchers to separate and recombine tissue compartments with greater control.
Precision Wound Research Depends on Better Human Models
The broader message is straightforward: immune-integrated models are becoming essential tools for understanding aberrant wound healing. They offer a way to study inflammation and fibrosis in a setting that better reflects human tissue behavior, and they may accelerate the development of therapies aimed at disordered repair. For investigators working on chronic wounds and pathological scars, the next step is not just building more complex systems. It is proving that those systems remain stable, reproducible, and biologically faithful enough to guide clinical translation.
Even with major advances in tissue engineering and microfluidics, the field still lacks fully standardized platforms that can model immune-driven skin repair across long culture periods. Until those gaps close, the most useful systems will be the ones that balance realism with reproducibility while preserving the immune behavior that defines the disease process.